# Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR

Study · id `cardio:ct-nct04767022` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04767022](<https://clinicaltrials.gov/study/NCT04767022>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04767022

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 224 participants.

## Technical summary

Registry record NCT04767022. Randomized; double masking; primary purpose treatment. Start 2021-01-30 (actual); primary completion 2023-12-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 224 participants (enrolled count; ClinicalTrials.gov record NCT04767022, source copy `cardio:ctgov-nct04767022-2025-02-21`, retrieved 2026-10-26)
- Started: 2021-01-30 (actual) (ClinicalTrials.gov record NCT04767022, source copy `cardio:ctgov-nct04767022-2025-02-21`, retrieved 2026-10-26)
- Primary completion: 2023-12-20 (actual) (ClinicalTrials.gov record NCT04767022, source copy `cardio:ctgov-nct04767022-2025-02-21`, retrieved 2026-10-26)
- Completion: 2024-05-30 (actual) (ClinicalTrials.gov record NCT04767022, source copy `cardio:ctgov-nct04767022-2025-02-21`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04767022, source copy `cardio:ctgov-nct04767022-2025-02-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04767022-2025-02-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR
- Condition: Coronary Artery Disease
- Intervention (Device): Paclitaxel Coated PTCA Balloon Catheter(Genoss® DCB)
- Intervention (Device): Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO)
- Lead sponsor: Genoss Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Genoss Co., Ltd. (`cardio:org-genoss-co-ltd`)

## Provenance

Content hash: f2a844960bd400ecaa9bcbeba094e63f66250e12dfdeef9851ce29d9041a795e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
